KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...

Discover how a newly recommended immunotherapy works by gradually increasing the body’s resistance to house dust mites.

Research indicates that between 17 and 40 million Americans suffer from vasomotor rhinitis and that Americans spend a minimum of $1.8 billion in treatment costs each year. A runny nose with drainage ...

A new study reveals that individuals with allergic rhinitis and asthma have distinct nasal fungal profiles, hinting at potential new treatment targets and the need for further investigation. Allergic ...

Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental ...

CNW/ - Pharmascience Canada is proud to announce the launch of  Pr  pms-RUPATADINE (rupatadine), a treatment that helps relieve nasal and non-nasal ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended Acarizax (12 ...

The most specific treatment for allergic rhinitis is immunotherapy. This involves repeated injections of a tiny amount of allergen, with the aim of desensitising your immune system. This type of ...

Rhinitis and pharmacological agents used for treatment are considered factors that could alter the rate and extent of absorption of drugs administered by the nasal route. The purpose of this study ...

The Chinese Medicine Unit, RMIT University, Bundoora, Victoria 3083, Australia Correspondence to: Dr. Charlie Changli Xue, Head and Senior Lecturer, The Chinese ...